Heidi Zhang, Executive Director, Global Head of Cell Therapy Analytical Development at Celgene discusses ways to overcome the challenges facing the cell and gene therapy industry, which include: manufacturing success rates, shortening “arm-to-arm” turnaround times and costs.
-----------------
Read more of our articles here: [ Ссылка ]
Sign up for free digital & physical copies here: [ Ссылка ]
This film was created by Texere Video Production. To find out more visit our website.
To discuss your own video needs contact our team at
video@texerepublishing.com
Subscribe to The Medicine Maker official YouTube channel here: [ Ссылка ]
Press the bell button to receive notifications whenever we post a new video.
Follow us and access our latest content:
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Linkedin: [ Ссылка ]
Instagram: [ Ссылка ]
Website: [ Ссылка ]
To follow what we are doing at Texere follow us:
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Linkedin: [ Ссылка ]
Instagram: [ Ссылка ]
Website: [ Ссылка ]
